ReviewCardiovascular diabetology2017

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.

Katherine Kearney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.